U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT02981602) titled 'Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naive Patients With Chronic HBV Infection' on Dec. 1, 2016.
Brief Summary: To examine the safety and tolerability of IONIS-HBVRx administration to treatment-naive patients with chronic hepatitis B virus infection
Study Type: Interventional
Condition: Chronic Hepatitis B Atypical
Intervention: * Drug: IONIS-HBVRx
Ascending multiple doses of IONIS-HBVRx by subcutaneous (SC) injection
Other Name: ISIS 505358
* Drug: Placebo
Placebo
Recruitment Status: Completed
Sponsor: Ionis Pharmaceuticals, Inc.
Information provided by (Responsible Par...